OpenURL Connection Search

Select item for more details and to access through your institution.

Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Published in:
Vaccines, 2024, v. 12, n. 4, p. 397, doi. 10.3390/vaccines12040397
By:
- Zelba, Henning;
- Kyzirakos, Christina;
- Kayser, Simone;
- Shao, Borong;
- Reinhardt, Annekathrin;
- Pieper, Natalia;
- Rabsteyn, Armin;
- Döcker, Dennis;
- Armeanu-Ebinger, Sorin;
- Kloor, Matthias;
- Hadaschik, Dirk;
- Schulze, Martin;
- Battke, Florian;
- Golf, Alexander;
- Biskup, Saskia
Publication type:
Article
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
Published in:
2020
By:
- Such, Lina;
- Zhao, Fang;
- Liu, Derek;
- Thier, Beatrice;
- Khanh Le-Trilling, Vu Thuy;
- Sucker, Antje;
- Coch, Christoph;
- Pieper, Natalia;
- Howe, Sebastian;
- Bhat, Hilal;
- Kalkavan, Halime;
- Ritter, Cathrin;
- Brinkhaus, Robin;
- Ugurel, Selma;
- Köster, Johannes;
- Seifert, Ulrike;
- Dittmer, Ulf;
- Schuler, Martin;
- Lang, Karl S.;
- Kufer, Thomas A.
Publication type:
journal article
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.
Published in:
Nature Communications, 2017, v. 8, n. 5, p. 15440, doi. 10.1038/ncomms15440
By:
- Sucker, Antje;
- Zhao, Fang;
- Pieper, Natalia;
- Heeke, Christina;
- Maltaner, Raffaela;
- Stadtler, Nadine;
- Real, Birgit;
- Bielefeld, Nicola;
- Howe, Sebastian;
- Weide, Benjamin;
- Gutzmer, Ralf;
- Utikal, Jochen;
- Loquai, Carmen;
- Gogas, Helen;
- Klein-Hitpass, Ludger;
- Zeschnigk, Michael;
- Westendorf, Astrid M.;
- Trilling, Mirko;
- Horn, Susanne;
- Schilling, Bastian
Publication type:
Article

Found: 3

Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.

Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.